Indian Healthcare Reforms : The Way Forward

India has 16 per cent of the world’s population, 18 per cent of the world’s mortality, 20 per cent of the world’s morbidity and healthcare expenditure in the country is a miniscule one per cent of global expenditure. As one of the fastest growing economies in the world, we cannot afford to rank 171 out of 175 amongst countries surveyed by the WHO in terms of percentage of GDP spent in public sector on healthcare.

In the same survey, India ranks 17th in terms of private sector spending on health which now contributes 4.3 per cent of the GDP spent on healthcare in the country. Amongst the BRIC countries India ranks the lowest with a 5.2 per cent of the GDP spent on healthcare while Brazil spends 7.6 per cent, Russia 6.1 per cent and China 5.4 per cent.

Its  time for the policy makers to  work on  some of the most important healthcare reforms

- Give infrastructure or national priority sector status to the sector to support and improve the overall investment in the sector both at the urban and rural level.

Govt spending on healthcare must increase to 2 per cent of the GDP from the current 0.9 per cent to provide higher outlay for healthcare infrastructure expansion and provision. Public and private healthcare combined spending should target 7 per cent of the GDP.

-Reallocation of resources of Govt spending on healthcare, higher outlay towards health insurance coverage schemes to widen affordability and accessibility.

- A national disease surveillance authority to be set up under the Ministry Of Health to consistently map, monitor and survey the prevalence of disease segments amongst the population in the country.

- Provide immediate impetus to grow the health insurance sector. Table and pass the Insurance reform bill to increase FDI in health insurance cos; to 49 per cent. Move towards compulsory health insurance coverage.

- Introduce healthcare investment zones to provide medical technology cos; and consumable manufacturer’s subsidized real estate and 10 year tax holiday to help local growth of this industry.

- Introduce a wellness tax incentive for employers towards implementation of preventive and wellness initiatives for employees and their families.

- Reform medical education system to enable higher private sector participation.

Posted in Healthcare Reforms, Indian Healthcare | Tagged , | Leave a comment

The Superbug Story:Undermining India’s growth Story in Healthcare

Over the last several weeks stories of the NDM superbug have been pasted across global media.

The Lancet report which first talked about this issue has been for years talking about the issues of MRSA (Multi Drug Resistant Staphylococcus Aureus) in UK hospitals. Ever since the first antibiotic “penicillin” was introduced in the 1940’s bacteria began to develop resistance to its effects and the cycle of innovating and researching new antibiotics began to take shape. Bacteria therefore do not get limited by geographical boundaries and similarly the use and overuse of antibiotics is not limited by geographies but has become prevalent worldwide. The data set in the report does not support the hypothesis that the superbug came or originated in India.

A total study of 37 patients from the UK out of which only 17 had a history of travelling to India and Pakistan is a miniscule sample size compared to the global community that criss crosses continents everyday on business and leisure apart from the medical travelers. The article does not conclusively state that the travelers picked the bug in India since all the UK Ecoli isolates were different from the strains picked in India and they could not prove a statistically significant strain relatedness between Indian and UK isolates.

It is ironical that in 2006 the same research team had reported a far more dangerous super bug from an infection outbreak in a hospital in Houston, Texas which was termed VIM 7. VIM 7 was resistant to all drugs except Polymixin B while NDM 1 is susceptible to Tigecyclin and Colistin.

One wonders why the research team did not choose the name VIM 7 as “ Houston Superbug “ while they chose to name NDM 1 AS “ New Delhi bug “ Viruses and Bacteria are a global phenomenon and outbreaks of new resistant bacterial strains are a way of life. The lancet article lists the presence of similar super bugs in other countries. In Jan 2009 UK health authorities issued a national resistance alert for stringent infection control since new bacteria were getting introduced in the country through patients with history of hospitalization in US, Greece, Turkey and Israel. India did not find a mention in that list.

The point therefore is that the issue of “Super Bugs” is prevalent in most developed and developing countries of the world. Hospital systems around the world spend each day of their life in giving a new lease of life to their patients, some now help to not only protect the lives of people in their own country but for the millions who travel from their country of origin to other countries in search of better and affordable healthcare. Medical globe trotters who visit the Fortis Hospitals in India have often described their experience of going through complex joint replacements, spinal surgeries and cardiac surgeries as truly life changing experience. They stand testimony to the most stringent standards that we follow to ensure patient safety and care.

The world therefore should spend less time in analyzing the country of origin of bacterial strains and spend more energy in getting the best medical minds together to innovate drugs to combat them. India has made significant strides in both forms of healthcare- be it Pharmaceuticals or in super specialty healthcare service delivery. What is probably the world’s latest is invariably India’s first in many of the advanced healthcare institutions in the country.

Most corporate hospitals have been accredited by the world’s most stringent accreditation bodies that go through intrinsic details before they accredit a hospital like the Joint Commission International Accreditation from the parent body JCAHO from the United States of America. We live in a globalised world where water, air and capital flows seamlessly and new solutions are found each day to issues that first seem to block free mobility and then become trivial. Medical Travel as a phenomenon has now anchored itself to save and enrich the lives of many and the controversy of NDM 1 has already sunk in the delight of all the positive experiences that patients from around the world have experienced in India

Posted in Healthcare Industry, Indian Healthcare, Medical Tourism | Tagged , | Leave a comment

About Me

Vishal Bali is the CEO for Fortis Hospitals Ltd which is part of the 48 Hospitals network of Fortis Healthcare Ltd.

Mr. Bali is recognized amongst the leaders in the change management of the healthcare delivery sector in India and is globally acknowledged for his contribution to the sector over the last two decades. Prior to his current assignment he was the CEO for Wockhardt Hospitals Group where he spent 19 yrs and established a pan India network of super speciality hospitals His expertise in management analysis and successfully integrating healthcare strategy, operations and management through information technology has set industry benchmarks. Mr. Bali completed his Bachelor’s in Science and Master’s in Business Administration from Bombay University and has completed an advance program in Hospital Management from Boston. Besides serving on the board of Fortis Hospitals ltd he is an invited member on the Strategic Initiatives group of Joint Commission International, US and on the Global Agenda Healthcare Council of the World Economic Forum. His keen interest in Globalization of healthcare and the evolving role of India has also led to a case study at the Harvard Business School. Mr Bali is a recipient of the Indian Healthcare Leader of the year by Express Healthcare for his role in shaping the growth of the healthcare sector in India. He is an active member of the Indian Healthcare Federation and Confederation of Indian Industry and is a globally recognized industry public speaker.

Posted in Vishal Bali | Leave a comment